EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 272 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $69,000 | -88.3% | 1,091 | -82.9% | 0.00% | -90.9% |
| Q1 2021 | $591,000 | +0.2% | 6,364 | -3.3% | 0.02% | -8.3% |
| Q4 2020 | $590,000 | +441.3% | 6,584 | +524.1% | 0.02% | +380.0% |
| Q3 2020 | $109,000 | +505.6% | 1,055 | +245.9% | 0.01% | +400.0% |
| Q1 2020 | $18,000 | +200.0% | 305 | +190.5% | 0.00% | – |
| Q4 2019 | $6,000 | +20.0% | 105 | 0.0% | 0.00% | – |
| Q3 2019 | $5,000 | 0.0% | 105 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | -44.4% | 105 | -26.6% | 0.00% | -100.0% |
| Q4 2018 | $9,000 | +800.0% | 143 | +652.6% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | -50.0% | 19 | -62.0% | 0.00% | – |
| Q3 2016 | $2,000 | -33.3% | 50 | -50.0% | 0.00% | -100.0% |
| Q2 2016 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
| Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
| AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
| RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
| EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
| SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
| Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
| DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |